Physician profile
Jay Gorstein
NPI 1255787537
$1,410.99
in general payments reported to CMS, 2019-2025
17 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.90 · 2020: $39.30 · 2021: $14.09 · 2022: $16.41 · 2024: $830 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $266.34 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $252.29 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $194.31 | 2024 | Cologuard Collection Kit |
| Corcept Therapeutics | $128.89 | 2024-2025 | Korlym |
| Tactile Systems Technology INC | $122.11 | 2024 | Entre Plus, Flexitouch Plus |
| Abbvie INC. | $97.82 | 2024-2025 | |
| Genentech USA, INC. | $68.29 | 2019-2021 | |
| Amgen INC. | $46.72 | 2024-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $39.13 | 2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $35.47 | 2024 | Shingrix, Arexvy |
| Intra-Sana Laboratories | $34.26 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Pfizer INC. | $26.64 | 2025 | |
| Sanofi-Aventis U.S. LLC | $26.36 | 2025 | |
| Optinose US, INC. | $21.00 | 2025 | |
| Verity Pharmaceuticals INC. | $19.78 | 2025 | Tlando |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $16.41 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $15.17 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Gorstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.